Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin in Adolescents with Dyslipidemia of Obesity
NCT02956590Phase 3Completed
- Sponsor
- Elevance Health
- Start
- May 2018
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pitavastatin in dyslipidemia, sponsored by Elevance Health. Started May 2018; status: completed.
02
Drugs
pitavastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02956590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956590.